Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-4681
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer ; day:5 ; month:4 ; year:2022 ; pages:1-10
Annals of surgical oncology ; (5.4.2022), 1-10
- Urheber
-
Kroese, Tiuri E.
Buijs, George S.
Burger, Matthijs D. L.
Ruurda, Jelle P.
Mook, Stella
Brosens, Lodewijk A. A.
Rossum, Peter S. N. van
Hillegersberg, Richard van
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1245/s10434-022-11541-0
- URN
-
urn:nbn:de:101:1-2022062321220049368064
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kroese, Tiuri E.
- Buijs, George S.
- Burger, Matthijs D. L.
- Ruurda, Jelle P.
- Mook, Stella
- Brosens, Lodewijk A. A.
- Rossum, Peter S. N. van
- Hillegersberg, Richard van
- SpringerLink (Online service)
Ähnliche Objekte (12)
ASO Visual Abstract: Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer
CyberKnife Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Gynecological Cancers
Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease
Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
Stereotactic body radiation therapy
ASO Author Reflections: Role of Local Treatment for Oligometastatic Esophagogastric Cancer
Influence of institutional experience and technological advances on outcome of stereotactic body radiation therapy for oligometastatic lung disease
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer
Induction therapy with 177Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patients
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer
ASO Visual Abstract: Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer
CyberKnife Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Gynecological Cancers
Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease
Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
Stereotactic body radiation therapy
ASO Author Reflections: Role of Local Treatment for Oligometastatic Esophagogastric Cancer
Influence of institutional experience and technological advances on outcome of stereotactic body radiation therapy for oligometastatic lung disease
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer
Induction therapy with 177Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patients
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer
ASO Visual Abstract: Metastasectomy or Stereotactic Body Radiation Therapy With or Without Systemic Therapy for Oligometastatic Esophagogastric Cancer
CyberKnife Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Gynecological Cancers
Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease
Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients
Stereotactic body radiation therapy
ASO Author Reflections: Role of Local Treatment for Oligometastatic Esophagogastric Cancer
Influence of institutional experience and technological advances on outcome of stereotactic body radiation therapy for oligometastatic lung disease
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer
Induction therapy with 177Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patients